NCT07039760 2026-03-11
Asciminib With or Without Sildenafil for Brain Tumors
Washington University School of Medicine
Phase EARLY_PHASE1 Not yet recruiting
Clinical Trials
11 trialsNCT07210632 2026-02-27
Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)
Vanderbilt-Ingram Cancer Center
Phase EARLY_PHASE1 Not yet recruiting
NCT05676489 2026-02-20
MeFAMP for Imaging System A Amino Acid Transport in Primary and Metastatic Brain Tumors
University of Alabama at Birmingham
Phase EARLY_PHASE1 Not yet recruiting
NCT07387666 2026-02-06
Imaging Acetadote Metabolism in Glioblastoma
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Not yet recruiting
NCT07244666 2025-11-24
Safety and Preliminary Efficacy of a Metabolically Armed Chimeric Antigen Receptor T Cell Therapy Targeting EGFRvIII for Recurrent Glioblastoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase EARLY_PHASE1 Not yet recruiting
NCT07090538 2025-07-29
GSL Synthetase Inhibitor Plus GM-CSF and/ or Immune Checkpoint Inhibitor in Previously Treated High-Risk Neuroblastoma.
Chinese PLA General Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT07026604 2025-06-18
CCM-DS01
Beijing Tiantan Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT06887673 2025-03-20
Lipid Mediators & Cancer: Montelukast, SPM, and Almonds
University of South Florida
Phase EARLY_PHASE1 Not yet recruiting
NCT06810336 2025-02-05
Pain Control and Quality of Recovery After Intravenous Methadone Versus Intravenous Remifentanil in Craniotomy Surgery
University of Virginia
Phase EARLY_PHASE1 Not yet recruiting
NCT06396481 2024-05-02
CSAγδTBMG
Beijing Tiantan Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT03763396 2024-03-08
Azoles Targeting Recurrent High Grade Gliomas
University Health Network, Toronto
Phase EARLY_PHASE1 Not yet recruiting